elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34085747-0DA720D0-5F37-4F54-A77C-91B932884EAA
Q34085747-0DA720D0-5F37-4F54-A77C-91B932884EAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34085747-0DA720D0-5F37-4F54-A77C-91B932884EAA
Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients
P2860
Q34085747-0DA720D0-5F37-4F54-A77C-91B932884EAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34085747-0DA720D0-5F37-4F54-A77C-91B932884EAA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7d6f55c70ec42e09a76e5d02140bf2357e4134d
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.